Sleep-related eating disorder caused by zolpidem: case report and review of the literature

Carmen Maura Carrillo de Albornoz, M. Guerrero-Jiménez, L. Gutiérrez-Rojas
{"title":"Sleep-related eating disorder caused by zolpidem: case report and review of the literature","authors":"Carmen Maura Carrillo de Albornoz, M. Guerrero-Jiménez, L. Gutiérrez-Rojas","doi":"10.5350/DAJPN2018310207","DOIUrl":null,"url":null,"abstract":"Sleep-related eating disorder caused by zolpidem: case report and review of the literature Sleep-related eating disorder (SRED) is a status characterized by recurrent episodes of eating high caloric foods and sometimes even toxic products at the transition from night-time sleep to arousal. The case presented is secondary to treatment with zolpidem, a hypnotic whose prescription rate has increased worldwide over the past few years. The authors report a case of SRED caused by zolpidem with important repercussions on the sleep structure and quality of life of our patient. The night eating episodes ceased promptly with zolpidem discontinuation, the sleep structure improved and the dayand night-time consequences disappeared. As in very few reported cases of zolpidem-induced SREDs, our patient had been suffering from parasomnia for a long time before the diagnosis. Reaching an understanding of the mechanism producing this type of parasomnias can be a guide for choosing the candidate profile before starting a zolpidem treatment. Active exclusion of symptoms suggestive of SREDs in patients under zolpidem treatment can avoid a significant deterioration in the quality of life of our patients. To our knowledge, there are no data focusing on the risk of parasomnias as a function of the sedative-hypnotic agent chosen. Here we present a case that may help address this issue.","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5350/DAJPN2018310207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Sleep-related eating disorder caused by zolpidem: case report and review of the literature Sleep-related eating disorder (SRED) is a status characterized by recurrent episodes of eating high caloric foods and sometimes even toxic products at the transition from night-time sleep to arousal. The case presented is secondary to treatment with zolpidem, a hypnotic whose prescription rate has increased worldwide over the past few years. The authors report a case of SRED caused by zolpidem with important repercussions on the sleep structure and quality of life of our patient. The night eating episodes ceased promptly with zolpidem discontinuation, the sleep structure improved and the dayand night-time consequences disappeared. As in very few reported cases of zolpidem-induced SREDs, our patient had been suffering from parasomnia for a long time before the diagnosis. Reaching an understanding of the mechanism producing this type of parasomnias can be a guide for choosing the candidate profile before starting a zolpidem treatment. Active exclusion of symptoms suggestive of SREDs in patients under zolpidem treatment can avoid a significant deterioration in the quality of life of our patients. To our knowledge, there are no data focusing on the risk of parasomnias as a function of the sedative-hypnotic agent chosen. Here we present a case that may help address this issue.
唑吡坦致睡眠相关进食障碍:病例报告及文献复习
唑吡坦引起的睡眠相关饮食障碍(sleep - relevant eating disorder, SRED)是一种以在夜间睡眠到觉醒的过渡阶段反复进食高热量食物,有时甚至是有毒食物为特征的状态。本病例继发于唑吡坦治疗,唑吡坦是一种催眠药,其处方率在过去几年中在世界范围内有所增加。作者报告了一例由唑吡坦引起的SRED,对患者的睡眠结构和生活质量产生了重要影响。停用唑吡坦后,夜间进食事件迅速停止,睡眠结构得到改善,白夜后果消失。由于很少有唑吡坦诱发的sred病例报道,我们的患者在诊断前已经患有睡眠异常很长时间。在开始唑吡坦治疗之前,了解产生这种类型的睡眠异常的机制可以作为选择候选特征的指南。在接受唑吡坦治疗的患者中,积极排除提示sred的症状可以避免患者生活质量的显著恶化。据我们所知,还没有数据表明睡眠异常的风险与所选择的镇静催眠剂的作用有关。在这里,我们提出一个可能有助于解决这个问题的案例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信